KA
LLY icon

Kooman & Associates’s Eli Lilly LLY Stock Holding History

Kooman & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Sell
386
-12
-3% -$12.3K 0.12% 36
2026
Q1 		$366K Sell
398
-11
-3% -$11.2K 0.11% 31
2025
Q4 		$440K Buy
409
+20
+5% +$19.1K 0.13% 30
2025
Q3 		$297K Sell
389
-1
-0.3% -$744 0.09% 44
2025
Q2 		$304K Sell
390
-12
-3% -$9.32K 0.1% 39
2025
Q1 		$332K Buy
402
+28
+7% +$23.3K 0.12% 34
2024
Q4 		$289K Sell
374
-1
-0.3% -$828 0.1% 38
2024
Q3 		$332K Sell
375
-11
-3% -$9.89K 0.12% 34
2024
Q2 		$349K Sell
386
-18
-4% -$14.4K 0.14% 33
2024
Q1 		$314K Buy
404
+10
+3% +$7.12K 0.13% 29
2023
Q4 		$230K Sell
394
-18
-4% -$10.5K 0.1% 37
2023
Q3 		$221K Sell
412
-35
-8% -$18K 0.11% 37
2023
Q2 		$210K Buy
+447
New +$187K 0.1% 40

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

Kooman & Associates's LLY Position: Q2 2026 in Review

Kooman & Associates reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $12.3K and leaving 386 shares worth $463K. The position accounts for 0.12% of the portfolio, ranked #36.

Kooman & Associates first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kooman & Associates held 386 shares of Eli Lilly worth $463K as of Q2 2026.
  • Kooman & Associates sold 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.12% of Kooman & Associates's portfolio in Q2 2026, its #36 holding.
  • Kooman & Associates first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kooman & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.